Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression

Insights

Scientists found that SIN3B protein is crucial for senescence in pancreatic cancer. Impairing SIN3B delayed tumor progression and reduced inflammation, suggesting SIN3B as a therapeutic target for pancreatic ductal adenocarcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) exhibits significant resistance to standard therapies.
  • The histone deacetylase-associated protein SIN3B was previously identified as essential for oncogene-induced senescence in cell cultures.

Purpose of the Study:

  • To investigate the role of SIN3B in activated KRAS-induced senescence in a mouse model of pancreatic cancer.
  • To explore the relationship between SIN3B, senescence, inflammation, and PDAC progression.
  • To evaluate SIN3B as a potential therapeutic target for inflammation-driven PDAC.

Main Methods:

  • Utilized a mouse model of pancreatic cancer to study SIN3B's function in vivo.
  • Genetically inactivated Sin3B to assess its impact on senescence and tumor progression.
  • Analyzed SIN3B levels and their correlation with KRAS-induced IL-1α production in murine and human pancreatic cells and tissues.
  • Compared SIN3B expression in control, PDAC, and pancreatic inflammation samples from human patients.

Main Results:

  • SIN3B was found to be required for activated KRAS-induced senescence in vivo.
  • Genetic inactivation of Sin3B led to delayed PDAC progression and an impaired inflammatory response.
  • SIN3B levels correlated with KRAS-induced IL-1α production in pancreatic cells and tissues.
  • SIN3B expression was decreased in PDAC samples compared to samples from patients with pancreatic inflammation.

Conclusions:

  • Senescence-associated inflammation positively correlates with PDAC progression.
  • SIN3B plays a critical role in regulating senescence and inflammation in pancreatic cancer.
  • SIN3B represents a potential therapeutic target for inhibiting inflammation-driven pancreatic tumorigenesis.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
30
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80%...
26